Sector Chart Myriad Genetics, Inc.
Stocks
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
05:00:00 07/11/2026 HKT
|
5-day change | 1st Jan Change | ||
| 5.920 USD | -5.88% |
|
-6.77% | -3.74% |
| 11-05 | Myriad Genetics, Inc., Q3 2026 Earnings Call, Nov 04, 2026 | |
| 11-05 | Myriad Genetics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Diagnostic & Testing Substances
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 568M | - | ||||
| 190B | |||||
| 125B | |||||
| 124B | |||||
| 99.31B | |||||
| 63.65B |
- Stock Market
- Stocks
- MYGN Stock
- Charts Myriad Genetics, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
